Message #20 From:
The Machine Date: February 16, 2008 02:09:46 AM
BCLI BrainStorm Cell Therapeutics -- Profile
BrainStorm Cell Therapeutics Inc. is an emerging company developing
neural-like stem cell therapeutic products, NurOwn(TM), based on
autologous bone marrow derived stromal cells, for treatment of
neurodegenerative diseases. NurOwn(TM) patent pending technology is
based on discoveries made by the team of prominent neurologist, Prof.
Eldad Melamed, Head of Neurology at Rabin Medical Center, and expert
cell biologist Dr. Daniel Offen, at the Felsenstein Medical Research
Center of Tel-Aviv University, enabling the differentiation of bone
marrow derived stem cells into functional neurons, as demonstrated in
animal models. The company holds rights to develop and commercialize
the technology through an exclusive, worldwide licensing agreement with
Ramot at Tel Aviv University Ltd., the technology transfer company of
Tel Aviv University. The company's initial focus is on developing
treatments for Parkinson's Disease.
